Table 2:
CMV Outcomes at 1 Year Follow-Up
| Ganciclovir (n=52) | Foscarnet (n=12) | P value | |
|---|---|---|---|
| Recurrence of CMV Viremia | 9 (16%) | 4 (33%) | 0.24 |
| CMV Disease | 2 (4%) | 0 (0%) | 1.00 |
| Death | 16 (28%) | 5 (42%) | 0.50 |
| Death with Positive CMV Viremia | 7 (13%) | 1 (8%) | 1.00 |
CMV Outcomes at 1 Year Follow-Up
| Ganciclovir (n=52) | Foscarnet (n=12) | P value | |
|---|---|---|---|
| Recurrence of CMV Viremia | 9 (16%) | 4 (33%) | 0.24 |
| CMV Disease | 2 (4%) | 0 (0%) | 1.00 |
| Death | 16 (28%) | 5 (42%) | 0.50 |
| Death with Positive CMV Viremia | 7 (13%) | 1 (8%) | 1.00 |